Every Cancer Journey is Unique.
It Should be Guided by Real Data.
THE APPROACH
THE CANFREE™ APPROACH TO CANCER
WHAT IS CANFREE™
Clarity through Comprehensive Cellular Analysis
Combining standard diagnostics — PET/CT, tissue biopsy — with real-time liquid biopsy analysis, for a fuller picture of your tumour's biology.
You and your medical team gain an objective, 360-degree understanding of your disease, supporting more informed discussions.
Navigated by Empowered Clinical Experts
Educational resources on liquid biopsy, cellular analysis, and metabolic nutrition, from our registered medical professionals.
Scientific resources give your medical team greater confidence navigating complex, data-guided clinical decisions.
At Oritov,
we use the CANFREE™ APPROACH TO CANCER to replace uncertainty with the clarity of real data.
Adaptive & Personalized Action Plans
Combining standard diagnostics with real-time liquid biopsy analysis — so your supportive strategy adapts as your biology changes over time.
Precise cellular data gives your medical team a clearer basis for supportive strategies shaped to your tumour's biology.
Real Data to Guide Decisions
Liquid biopsy tests monitor circulating tumour cells & cancer stem cells — an added layer alongside standard imaging.
Real-time cellular data supports informed treatment discussions — rather than waiting months for changes to show on a scan.
Empowerment Through a Global Clinical Ecosystem
We connect you to global oncology research, precision laboratories, and data tools — beyond limited local resources.
Comprehensive scientific information gives you the confidence to actively partner with your medical team and advocate for your care.
Fueling Metabolic Resilience
Cancer alters cellular metabolism — we support that with evidence-based nutritional strategies for cellular health.
Supporting your overall wellbeing and physical resilience, to help you stay prepared throughout treatment.
Evidence-Based Synergistic Integration
Peer-reviewed evidence, like testing Berberine against your specific cancer cells, to see what complements treatment.
An evidence-informed integrative approach that helps identify potential drug–supplement interactions across your available therapies.
Liquid Biopsy in Singapore
Beyond the Tumour
THE RESULT
Liquid Biopsy
Bringing Clarity to Your Cancer Biology
Beyond the Tumour
Understand how your cancer may be behaving beyond the primary tumour site
Living Cell Response
Understand how your living cancer cells may respond to different therapies in the laboratory
Sharper Clarity
Build a clearer, more complete biological picture to guide treatment discussions with greater confidence
METABOLIC NUTRITION
Nutritional Strategies
While your medical team addresses the disease directly, your body’s ability to stay strong throughout treatment matters just as much.
THE RESULT
Metabolic Nutrition
Fuelling Your Body's Resiliency
Nutritional Strategies
Develop more personalised nutritional strategies informed by your biological information
Metabolic Health
Support your overall wellbeing, metabolic health, and physical resilience during active treatment
Evidence-informed
Provide evidence-informed nutritional and supplementation strategies that complement your standard medical care
CLINICAL EXPERT NETWORK
Biological Insight
Having the right data and nutritional strategies means little without the right people to act on them.
The CANFREE™ APPROACH TO CANCER framework is built on the belief that an empowered, well-equipped medical team is your greatest asset in navigating cancer.
We work alongside your medical team, empowering them with additional biological information, evidence-informed resources, and educational support to facilitate more informed care discussions.
THE RESULT
Clinical Expert Network
Empowering Your Medical Team to Serve You Better
Biological Insight
Insights that provide additional biological information to support clinical discussions
Evidence-Based
Evidence-based metabolic nutrition protocols informed by your biological information
Access to Specialists
Access to a growing network of practitioners trained in the CANFREE™ APPROACH TO CANCER Framework
THE RESULT
Partnering With Your Medical Team
Supporting More Informed Conversations About Your Care
Continue Your Journey
Your cancer journey is unique.
Auto-scrolling overview — hover to pause and explore.
FREQUENTLY ASKED QUESTIONS
What is the CANFREE™ APPROACH TO CANCER?
The CANFREE™ APPROACH TO CANCER is Oritov’s educational approach to helping patients and families better understand cancer as a broader biological picture. It brings together education on topics such as Liquid Biopsy, Metabolic Nutrition, and patient navigation to support more informed discussions with your medical team.
Does Liquid Biopsy replace a tissue biopsy or my hospital treatment?
No. Liquid Biopsy is designed to complement—not replace—standard tissue biopsy, hospital investigations, or treatment recommended by your medical team. Any clinical decisions remain with your medical team.
How does Oritov support patients and their medical team?
Oritov provides education, helps patients better understand complex cancer topics, and, where appropriate, coordinates access to clinician-directed laboratory testing pathways. Our role is to support understanding alongside your standard medical care—not replace it.
Why is Metabolic Nutrition part of the CANFREE™ APPROACH TO CANCER?
The CANFREE™ APPROACH TO CANCER recognises that cancer affects more than a single tumour. Researchers continue to study metabolism, nutrition, and cellular health in the context of cancer. Oritov provides educational resources to help patients better understand these topics alongside conventional cancer care.
How do I get started?
You can begin by exploring our educational resources, downloading the CANFREE™ APPROACH TO CANCER Guide, or speaking with our team. If clinician-directed laboratory testing is appropriate for your situation, we can explain the process and help coordinate with your medical team where appropriate.
Download
The CANFREE™ Approach to Cancer Guide Download
CLINICAL LITERATURE CITATIONS
Study: Winther, H., et al. (2020). “Multidisciplinary treatment of unresectable colorectal liver metastases (CRCLM) using liquid biopsy precision oncotherapy in selecting drugs in comparison to tissue biopsy.” Journal of Cancer Research and Clinical Oncology.
Study: Papasotiriou, I., et al. (2015). “Circulating tumor cells isolation and characterization in many cancer types: An alternative fluidic-based method.” Journal of Cancer Therapy.
Study: Maier, T., Serrano, L., et al. (2009). “Correlation of mRNA and protein in complex biological samples.” Nature FEBS Letters.
Study: Friberg, S., & Mattson, S. (1997). “On the growth rates of human malignant tumors.” Journal of Surgical Oncology.

